| 000 | 00971 a2200265 4500 | ||
|---|---|---|---|
| 005 | 20250517144334.0 | ||
| 264 | 0 | _c20180212 | |
| 008 | 201802s 0 0 eng d | ||
| 022 | _a1522-9645 | ||
| 024 | 7 |
_a10.1093/eurheartj/ehx110 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSteg, Philippe Gabriel | |
| 245 | 0 | 0 |
_aDuration of antiplatelet therapy after DES implantation: can we trust non-inferiority open-label trials? _h[electronic resource] |
| 260 |
_bEuropean heart journal _c04 2017 |
||
| 300 |
_a1044-1047 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Comment | ||
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aDrug-Eluting Stents |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aPlatelet Aggregation Inhibitors |
| 650 | 0 | 4 | _aTiclopidine |
| 700 | 1 | _aSimon, Tabassome | |
| 773 | 0 |
_tEuropean heart journal _gvol. 38 _gno. 14 _gp. 1044-1047 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/eurheartj/ehx110 _zAvailable from publisher's website |
| 999 |
_c27002994 _d27002994 |
||